EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Zinc finger transcription factor Egf1 promotes non-alcoholic fatty liver disease

Yan Guo, Xiulian Miao, Xinyue Sun, Luyang Li, Anqi Zhou, Xi Zhu, Yong Xu, Qinghua Wang, Zilong Li, Zhiwen Fan

JHEP Reports · 2023-06 · 5 (6) · 100724

DOI: 10.1016/j.jhepr.2023.100724 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JHEP Reports, 2023-06. Verfasst von Yan Guo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biomedical Research and College of Life Sciences, Liaocheng University, Liaocheng, China. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Natural Science Foundation of Jiangsu Province, Liaocheng University, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background & Aims: Non-alcoholic fatty liver disease (NAFLD) contributes to the global epidemic of metabolic syndrome and is considered a prelude to end-stage liver diseases such as cirrhosis and hepatocellular carcinoma. During NAFLD pathogenesis, hepatic parenchymal cells (hepatocytes) undergo both morphological and functional changes owing to a rewired transcriptome. The underlying mechanism is not entirely clear. In the present study, we investigated the involvement of early growth response 1 (Egr1) in NAFLD.

Methods

Quantitative PCR, Western blotting, and histochemical staining were used to assess gene expression levels. Chromatin immunoprecipitation was used to evaluate protein binding to DNA. NAFLD was evaluated in leptin receptor-deficient (db/db) mice.

Results

We report here that Egr1 was upregulated by pro-NAFLD stimuli in vitro and in vivo. Further analysis revealed that serum response factor (SRF) was recruited to the Egr1 promoter and mediated Egr1 transactivation. Importantly, Egr1 depletion markedly mitigated NAFLD in db/db mice. RNA sequencing revealed that Egr1 knockdown in hepatocytes, on the one hand, boosted fatty acid oxidation (FAO) and, on the other hand, suppressed the synthesis of chemoattractants. Mechanistically, Egr1 interacted with peroxisome proliferator-activated receptor α (PPARα) to repress PPARα-dependent transcription of FAO genes by recruiting its co-repressor NGFI-A binding protein 1 (Nab1), which potentially led to promoter deacetylation of FAO genes.

Conclusions

Our data identify Egr1 as a novel modulator of NAFLD and a potential target for NAFLD intervention. Impact and Implications: Non-alcoholic fatty liver disease (NAFLD) precedes cirrhosis and hepatocellular carcinoma. In this paper, we describe a novel mechanism whereby early growth response 1 (Egr1), a transcription factor, contributes to NAFLD pathogenesis by regulating fatty acid oxidation. Our data provide novel insights and translational potential for NAFLD intervention.

Schlagwörter

Stichwörter der Autor:innen

HepatocyteNon-alcoholic fatty liver diseaseTranscription factorTranscriptional regulation

Autor:innen und Institutionen

  • Institute of Biomedical Research and College of Life Sciences, Liaocheng University, Liaocheng, China.
  • State Key Laboratory of Natural Medicines, Department of Pharmacology, China Pharmaceutical University, Nanjing, China.
  • Department of Oral Medicine, Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing, China.
  • Department of Infectious Diseases, Kunshan First People's Hospital Affiliated to Jiangsu University, Kunshan, China.
  • Department of Gastroenterology, Kunshan First People's Hospital Affiliated to Jiangsu University, Kunshan, China.
  • Department of Pathology, Affiliated Nanjing Drum Tower Hospital, Nanjing University School of Medicine, Nanjing, China.

Förderung

  • Natural Science Foundation of Jiangsu Province
  • Liaocheng University
  • National Natural Science Foundation of China

Zitieren

APA

Guo, Y., Miao, X., Sun, X., Li, L., Zhou, A., Zhu, X., Xu, Y., Wang, Q., Li, Z., & Fan, Z. (2023). Zinc finger transcription factor Egf1 promotes non-alcoholic fatty liver disease. JHEP Reports, 5(6), 100724. https://doi.org/10.1016/j.jhepr.2023.100724

Vancouver

Guo Y, Miao X, Sun X, Li L, Zhou A, Zhu X, et al. Zinc finger transcription factor Egf1 promotes non-alcoholic fatty liver disease. JHEP Reports. 2023;5(6):100724. doi:10.1016/j.jhepr.2023.100724

BibTeX
@article{Guo2023,
  author = {Guo, Yan and Miao, Xiulian and Sun, Xinyue and Li, Luyang and Zhou, Anqi and Zhu, Xi and Xu, Yong and Wang, Qinghua and Li, Zilong and Fan, Zhiwen},
  title = {Zinc finger transcription factor Egf1 promotes non-alcoholic fatty liver disease},
  journal = {JHEP Reports},
  year = {2023},
  volume = {5},
  number = {6},
  pages = {100724},
  doi = {10.1016/j.jhepr.2023.100724}
}
Kostenlos starten →